| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 660182 | 69434 | ENALAPRIL/ HIDROCLOROTIAZIDA PENSA 20/12,5 mg COMPRIMIDOS EFG | ENALAPRIL/ HIDROCLOROTIAZIDA PENSA 20/12,5 mg COMPRIMIDOS EFG , 28 comprimidos | 20 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69434/69434_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69434/69434_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 40831 | TOWA PHARMACEUTICAL S.A. | 2007-12-03 | 1 | 1 | 1 | 2007-12-03 | 2007-12-03 | 1 | 2011-06-16 | View Edit Delete | ||||||||||||
| 658953 | 07387014 | ADVAGRAF 0,5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA | ADVAGRAF 0,5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA, 30 cápsulas | 0,5 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07387014/07387014_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07387014/07387014_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 13990 | ASTELLAS PHARMA S.A. | 2012-07-24 | 1 | 1 | 1 | 2012-07-24 | 2012-07-24 | 1 | 2023-10-24 | View Edit Delete | ||||||||||||
| 658954 | 07387017 | ADVAGRAF 1 MG CAPSULAS DURAS DE LIBERACION PROLONGADA | ADVAGRAF 1 MG CAPSULAS DURAS DE LIBERACION PROLONGADA 30 cápsulas | 1 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07387017/07387017_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07387017/07387017_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 13990 | ASTELLAS PHARMA S.A. | 2012-07-24 | 1 | 1 | 1 | 2012-07-24 | 2012-07-24 | 1 | 2023-10-24 | View Edit Delete | ||||||||||||
| 658956 | 07387019 | ADVAGRAF 1 MG CAPSULAS DURAS DE LIBERACION PROLONGADA | ADVAGRAF 1 MG CAPSULAS DURAS DE LIBERACION PROLONGADA, 60 cápsulas | 1 mg | 5 | 60 | 43 | 60 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07387019/07387019_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07387019/07387019_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 13990 | ASTELLAS PHARMA S.A. | 2012-07-24 | 1 | 1 | 1 | 2012-07-24 | 2012-07-24 | 1 | 2023-10-24 | View Edit Delete | ||||||||||||
| 658957 | 07387024 | ADVAGRAF 5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA | ADVAGRAF 5 MG CAPSULAS DURAS DE LIBERACION PROLONGADA, 30 cápsulas | 5 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07387024/07387024_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07387024/07387024_p.pdf | 1 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 13990 | ASTELLAS PHARMA S.A. | 2012-07-24 | 1 | 1 | 1 | 2012-07-24 | 2012-07-24 | 1 | 2023-10-24 | View Edit Delete | ||||||||||||
| 658516 | 68201 | TRIFLUSAL CINFA 300 mg CAPSULAS DURAS EFG | TRIFLUSAL CINFA 300 mg CAPSULAS DURAS EFG, 30 cápsulas | 300 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68201/68201_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68201/68201_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-02-01 | 1 | 1 | 1 | 2007-02-01 | 2007-02-21 | 0 | 2011-10-19 | View Edit Delete | ||||||||||||
| 658780 | 68627 | NORFLOXACINO CINFA 400 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | NORFLOXACINO CINFA 400 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 14 comprimidos | 400 mg | 5 | 14 | 10 | 14 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68627/68627_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68627/68627_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-03-29 | 1 | 1 | 1 | 2007-03-29 | 2007-03-29 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 659096 | 68823 | OLANZAPINA CINFA 2,5 mg COMPRIMIDOS EFG | OLANZAPINA CINFA 2,5 mg COMPRIMIDOS EFG, 28 comprimidos | 2,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68823/68823_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68823/68823_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-05-28 | 1 | 1 | 1 | 2007-05-28 | 2007-05-28 | 1 | 2011-08-01 | View Edit Delete | ||||||||||||
| 659104 | 68828 | OLANZAPINA CINFA 5 mg COMPRIMIDOS EFG | OLANZAPINA CINFA 5 mg COMPRIMIDOS EFG, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68828/68828_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68828/68828_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-05-28 | 1 | 1 | 1 | 2007-05-28 | 2007-05-28 | 1 | 2011-08-01 | View Edit Delete | ||||||||||||
| 659105 | 68829 | OLANZAPINA CINFA 7,5 mg COMPRIMIDOS EFG | OLANZAPINA CINFA 7,5 mg COMPRIMIDOS EFG, 56 comprimidos | 7,5 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68829/68829_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68829/68829_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-05-28 | 1 | 1 | 1 | 2007-05-28 | 2007-05-28 | 1 | 2011-08-01 | View Edit Delete | ||||||||||||
| 659106 | 68830 | OLANZAPINA CINFA 10 mg COMPRIMIDOS EFG | OLANZAPINA CINFA 10 mg COMPRIMIDOS EFG, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68830/68830_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68830/68830_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-05-28 | 1 | 1 | 1 | 2007-05-28 | 2007-05-28 | 1 | 2011-08-01 | View Edit Delete | ||||||||||||
| 659107 | 68830 | OLANZAPINA CINFA 10 mg COMPRIMIDOS EFG | OLANZAPINA CINFA 10 mg COMPRIMIDOS EFG, 56 comprimidos | 10 mg | 5 | 56 | 10 | 56 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68830/68830_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68830/68830_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-05-28 | 1 | 1 | 1 | 2007-05-28 | 2007-05-28 | 1 | 2011-08-01 | View Edit Delete | ||||||||||||
| 659477 | 69057 | LOSARTAN/HIDROCLOROTIAZIDA CINFA 50 mg/ 12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LOSARTAN/HIDROCLOROTIAZIDA CINFA 50 mg/ 12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 50 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69057/69057_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69057/69057_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-06-29 | 1 | 1 | 1 | 2007-06-29 | 2007-06-29 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 659517 | 69086 | TERAZOSINA CINFA 2 mg COMPRIMIDOS EFG | TERAZOSINA CINFA 2 mg COMPRIMIDOS EFG , 15 comprimidos | 2 mg | 5 | 15 | 10 | 15 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69086/69086_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69086/69086_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-07-06 | 1 | 1 | 1 | 2007-07-06 | 2007-07-06 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 659518 | 69087 | TERAZOSINA CINFA 5 mg COMPRIMIDOS EFG | TERAZOSINA CINFA 5 mg COMPRIMIDOS EFG, 30 comprimidos | 5 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69087/69087_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69087/69087_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-07-06 | 1 | 1 | 1 | 2007-07-06 | 2007-07-06 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 659531 | 69093 | MELOXICAM CINFA 7,5 mg COMPRIMIDOS EFG | MELOXICAM CINFA 7,5 mg COMPRIMIDOS EFG, 20 comprimidos | 7,5 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69093/69093_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69093/69093_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-07-10 | 1 | 1 | 1 | 2007-07-10 | 2007-07-10 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 659533 | 69094 | MELOXICAM CINFA 15 mg COMPRIMIDOS EFG | MELOXICAM CINFA 15 mg COMPRIMIDOS EFG, 20 comprimidos | 15 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69094/69094_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69094/69094_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-07-10 | 1 | 1 | 1 | 2007-07-10 | 2007-07-10 | 1 | 2011-10-19 | View Edit Delete | ||||||||||||
| 659660 | 69161 | VENLAFAXINA RETARD CINFAMED 150 mg CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | VENLAFAXINA RETARD CINFAMED 150 mg CAPSULAS DURAS DE LIBERACION PROLONGADA EFG , 30 cápsulas | 150 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69161/69161_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69161/69161_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-07-25 | 1 | 1 | 1 | 2007-07-25 | 2007-07-25 | 1 | 2018-06-15 | View Edit Delete | ||||||||||||
| 659661 | 69162 | VENLAFAXINA RETARD CINFAMED 75 mg CAPSULAS DURAS DE LIBERACION PROLONGADA EFG | VENLAFAXINA RETARD CINFAMED 75 mg CAPSULAS DURAS DE LIBERACION PROLONGADA EFG , 30 cápsulas | 75 mg | 5 | 30 | 43 | 30 cápsulas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69162/69162_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69162/69162_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-07-25 | 1 | 1 | 1 | 2007-07-25 | 2007-07-25 | 1 | 2018-06-15 | View Edit Delete | ||||||||||||
| 659725 | 69197 | CINFAMAR CAFEINA 50 mg/50 mg COMPRIMIDOS RECUBIERTOS | CINFAMAR CAFEINA 50 mg/50 mg COMPRIMIDOS RECUBIERTOS , 4 comprimidos | 50 mg/50 mg | 5 | 4 | 10 | 4 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/69197/69197_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/69197/69197_p.pdf | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 684 | LABORATORIOS CINFA S.A. | 2007-07-30 | 1 | 1 | 1 | 2007-07-30 | 2007-07-30 | 1 | 2011-10-19 | View Edit Delete |
Page 142 of 1034, showing 20 records out of 20674 total, starting on record 2821, ending on 2840